PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $644,788 | -64.5% | 37,185 | -62.9% | 0.00% | – |
| Q2 2023 | $1,816,004 | -10.8% | 100,221 | +31.0% | 0.00% | – |
| Q1 2023 | $2,035,485 | +394.4% | 76,522 | +259.2% | 0.00% | – |
| Q4 2022 | $411,748 | -72.0% | 21,301 | -69.7% | 0.00% | – |
| Q3 2022 | $1,470,000 | +1236.4% | 70,357 | +413.6% | 0.00% | – |
| Q2 2022 | $110,000 | -12.0% | 13,699 | -23.2% | 0.00% | – |
| Q1 2022 | $125,000 | -64.3% | 17,836 | -31.1% | 0.00% | – |
| Q4 2021 | $350,000 | +7.0% | 25,876 | +33.3% | 0.00% | – |
| Q3 2021 | $327,000 | +30.3% | 19,408 | +125.0% | 0.00% | – |
| Q2 2021 | $251,000 | -7.0% | 8,624 | +25.8% | 0.00% | – |
| Q1 2021 | $270,000 | +357.6% | 6,856 | +166.1% | 0.00% | – |
| Q4 2020 | $59,000 | +321.4% | 2,576 | +313.5% | 0.00% | – |
| Q3 2020 | $14,000 | – | 623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |